BOSTON ( TheStreet) -- U.S. stocks slid last month, with the S&P 500 falling 4.7% as investors loaded up on fixed-income securities. Here are 10 stocks struggling despite exceptionally cheap price-to-earnings ratios. When stocks rebound, these stocks may fare best. The companies are ordered by forward earnings multiple, from cheap to cheapest.

10. Humana ( HUM) offers health and supplemental benefit plans. Second-quarter profit increased 21% to $340 million, or $2 a share, as revenue grew 9.5% to $8.7 billion. The operating margin rose from 5.9% to 8.2%. Humana has $8.9 billion of cash and $1.7 billion of debt, equal to a quick ratio of 1.7 and a debt-to-equity ratio of 0.3. During the past three years, Humana has grown revenue 11% annually, on average, and boosted profit 24% a year.

Its stock trades at a trailing earnings multiple of 7.1, a forward earnings multiple of 8.6, a book value multiple of 1.3, a sales multiple of 0.3 and a cash flow multiple of 3.6 -- 51%, 31%, 48%, 60% and 59% discounts to peer averages. Of analysts covering Humana, 9, or 43%, advise purchasing its shares, 11 recommend holding and one suggests selling them. A median price target of $55.73 suggests a return of 16%.

9. Goldman Sachs ( GS) is a global full-service investment bank. Second-quarter profit tumbled 82% to $613 million, or 78 cents a share, as revenue decreased 31% to $10 billion. The operating margin narrowed from 42% to 40%. Goldman Sachs has $258 billion of cash and $540 billion of debt, equal to an elevated debt-to-equity ratio of 7.3. Since 2007, Goldman has increased net income 5.9% a year, though earnings per share fell 2.6% a year.

Its stock sells for a trailing earnings multiple of 7.2, a forward earnings multiple of 7.7, a book value multiple of 1, a sales multiple of 1.5 and a cash flow multiple of 2.1 -- 46%, 45%, 35%, 31% and 85% discounts to capital markets industry averages. Of researchers following Goldman, 24, or 86%, rate its stock "buy" and four rate it "hold." None rank it "sell." A median target of $189.79 implies 39% of upside. Deutsche Bank ( DB) offers a price target of $205.

8. SLM Corp. ( SLM) provides education finance in the U.S. SLM swung to a second-quarter profit of $338 million, or 63 cents a share, from a loss of $123 million, or 31 cents, a year earlier. Revenue gained 13%. The operating margin narrowed from 61% to 57%. SLM Corp. holds $13 billion of cash and $199 billion of debt, equal to an excessive debt-to-equity ratio of 39. During the past three years, SLM's net income has dropped 8.5% a year, on average.

Its stock trades at a trailing earnings ratio of 5.4, a forward earnings multiple of 7.7, a book value multiple of 1.1 and a sales multiple of 0.8 -- 58%, 37%, 51% and 43% discounts to consumer finance industry averages. Of analysts evaluating SLM Corp., six, or 60%, rate its stock "buy" and four rate it "hold." None rank it "sell." A median target of $15.50 suggests a potential return of 40%. FBR ( FBCM) offers a price target of $19, implying 71% of upside.

7. Coventry Health Care ( CVH) is a managed-health-care company. Its second-quarter profit plummeted 95% to $1 million, or 1 cent per share, as revenue fell 18% to $2.9 billion. The operating margin extended from 2.9% to 9.9%. Coventry has $1.5 billion of cash and $1.6 billion of debt, converting to a quick ratio of 1 and a debt-to-equity ratio of 0.4. Since 2007, Coventry has grown sales 14% annually, on average, as net profit dropped 22% a year.

Its stock sells for a trailing earnings multiple of 9.5, a forward earnings multiple of 7.7, a book value multiple of 0.8, a sales multiple of 0.2 and a cash flow multiple of 8.6 -- 35%, 38%, 68%, 63% and 2% discounts to health care peer averages. Of researchers covering Coventry, six, or 32%, advocate purchasing its shares and 13 recommend holding them. A median price target of $25.64 suggests a return of 31%. BMO ( BMO) offers a price target of $33.

6. Ace ( ACE) provides a range of insurance and reinsurance products. Second-quarter profit expanded 27% to $677 million, or $1.98 a share, as revenue increased 6% to $3.8 billion. The operating margin widened from 19% to 23%. Ace has $5 billion of cash and $3.6 billion of debt, equal to a debt-to-equity ratio of 0.2. Since 2007, Ace has grown sales 4.1% a year, on average, increased net income 3.6% a year and boosted earnings per share 3% a year.

Its stock trades at a trailing earnings multiple of 6.3, a forward earnings multiple of 7.3, a book value multiple of 0.9, a sales multiple of 1.2 and a cash flow multiple of 4.9 -- 58%, 27%, 80%, 76% and 44% discounts to insurance industry averages. Of analysts covering Ace, 21, or 88%, rate its stock "buy" and three rate it "hold." None rank it "sell." A median target of $65.98 implies 24% of upside. JPMorgan ( JPM) forecasts that the stock will rise 37% to $73.

5. Ford ( F) designs and manufactures cars and trucks. Ford's second-quarter net income increased 15% to $2.6 billion, but earnings per share fell 12% to 61 cents, hurt by a higher share count. Revenue gained 31% to $35 billion. The operating margin turned positive. The balance sheet stores $31 billion of cash and $117 billion of debt. Ford is running a shareholders' deficit, but it has decreased 67% since the year-earlier quarter to $3.6 billion.

Its stock sells for a trailing earnings multiple of 6.8, a forward earnings multiple of 5.8, a sales multiple of 0.3 and a cash flow multiple of 3.1 -- 63%, 76%, 42% and 10% discounts to auto peer averages. Of researchers following Ford, nine, or 56%, rate its stock "buy", six rate it "hold" and one ranks it "sell." A median target of $15.90 suggests a return of 42%. UBS ( UBS) predicts the stock will advance 51% to $17.

4. SuperValu ( SVU) operates retail food stores in the U.S. under a variety of names, including Shaw's. The company's fiscal first-quarter profit tumbled 41% to $67 million, or 31 cents a share, as revenue declined 9% to $12 billion. The operating margin tightened from 2.9% to 2.8%. SuperValu holds $198 million of cash and $7.4 billion of debt, equal to a low quick ratio of 0.2 and a high debt-to-equity ratio of 2.5. SuperValu's sales have fallen 4.2% a year since 2007.

SuperValu's stock trades at a trailing earnings multiple of 6.2, a forward earnings multiple of 5.6, a book value multiple of 0.7, a sales multiple of 0.1 and a cash flow multiple of 1.6 -- 93%, 58%, 71%, 88% and 80% discounts to food and staples retailing industry averages. Of analysts covering SuperValu, one, or 7%, advises purchasing its shares, 12 recommend holding and two suggest selling them. A median target of $12.23 suggests a potential return of 26%.

3. Gannett ( GCI) owns numerous regional and national newspapers, including USA Today, and online news sites. Second-quarter profit more than doubled to $195 million, or 73 cents a share, as revenue declined 1.6% to $1.4 billion. The operating margin rose from 15% to 20%. Gannett has $157 million of cash and $2.6 billion of debt, converting to a quick ratio of 1 and a debt-to-equity ratio of 1.4.

Its stock sells for a trailing earnings multiple of 5.8, a forward earnings multiple of 5.1, a book value multiple of 1.5, a sales multiple of 0.5 and a cash flow multiple of 3.2 -- 71%, 79%, 54%, 76% and 77% discounts to media peer averages. Of researchers following Gannett, six, or 86%, rate its stock "buy" and one rates it "hold." None rank it "sell." A median target of $21 implies 74% of upside. Evercore ( EVR) forecasts that the stock will rise 49% to $18.

2. Western Digital ( WDC) designs and sells hard-drives. Fiscal fourth-quarter profit increased 35% to $264 million, or $1.13 a share, as revenue gained 23% to $2.4 billion. The operating margin extended from 9.6% to 13%. Western Digital has $2.7 billion of cash and $400 million of debt, translating to a quick ratio of 2 and a debt-to-equity ratio of 0.1. Since 2007, Western Digital has grown sales 23% annually, on average, and boosted net income 35% a year.

Its stock trades at a trailing earnings multiple of 4, a forward earnings multiple of 5.1, a book value multiple of 1.2, a sales multiple of 0.6 and a cash flow multiple of 2.8, 77%, 66%, 70%, 79% and 76% discounts to computers and peripherals industry averages. Of analysts covering Western Digital, 13, or 52%, rate its stock "buy", nine rate it "hold" and three rank it "sell." A median target of $36.21 implies 50% of upside.

1. Micron Technology ( MU) designs and makes semiconductors. The company swung to a fiscal third-quarter profit of $939 million, or 92 cents a share, from a loss of $301 million, or 37 cents, a year earlier. Revenue more than doubled. The operating margin turned positive. Micron holds $2.3 billion of cash and $2.6 billion of debt, equal to a quick ratio of 1.5 and a debt-to-equity ratio of 0.3. Since 2007, Micron has expanded net income 154% a year.

Micron's stock sells for a trailing earnings multiple of 4.7, a forward earnings multiple of 3.7, a book value multiple of 0.9, a sales multiple of 0.9 and a cash flow multiple of 2.8 -- 75%, 68%, 83%, 69% and 79% discounts to semiconductor industry averages. Of researchers following Micron, 17, or 74%, advocate purchasing Micron's shares, five recommend holding and one says to sell them. A median target of $14.06 suggests a potential return of 118%.

-- Written by Jake Lynch in Boston.

RELATED STORIES:



Become a fan of TheStreet on Facebook.
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

If you liked this article you might like

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

Why Centene Is One of Jim Cramer's 'Absolute Favorite Stocks'

Why Centene Is One of Jim Cramer's 'Absolute Favorite Stocks'

Wall Street Volatility, Disney, Snap and Steve Wynn - 5 Things You Must Know

Wall Street Volatility, Disney, Snap and Steve Wynn - 5 Things You Must Know

Investors Are Trying to Figure Out the 'Powell Put'

Investors Are Trying to Figure Out the 'Powell Put'

Bullish Humana Stock Should Keep 'HUM'ming Along

Bullish Humana Stock Should Keep 'HUM'ming Along